Rilpivirine: The Key for Long-term Success. | AIDS Rev;19(3): 156-166, 2017. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Rilpivirine: The Key for Long-term Success.

Viciana, Pompeyo.

Affiliation

Viciana P; Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine, HIV and PK Research Group, Institute of Biomedicine of Seville (IBiS), University of Seville, CSIC, University Hospital Virgen del Rocío, Sevilla, Spain.

AIDS Rev ; 19(3): 156-166, 2017.

Article in En | MEDLINE | ID: mdl-29066858

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Rilpivirine Limits: Humans Language: En Journal: AIDS Rev Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2017 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Rilpivirine Limits: Humans Language: En Journal: AIDS Rev Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2017 Document type: Article Affiliation country: Country of publication: